Edith Cowan University (ECU) researchers have developed the world’s first blood test capable of detecting melanoma in its early stages, a breakthrough that will save thousands of lives, as well as millions of dollars for the health system.
In a trial involving 105 people with melanoma and 104 healthy controls, the blood test was able to detect early stage melanoma in 79 per cent of cases.
Australia has the second highest rate of melanoma in the world, with 14,000 new diagnoses and almost 2000 deaths each year.
Lead researcher PhD candidate Pauline Zaenker said identifying melanoma early was the best way to preventing these deaths.
“Patients who have their melanoma detected in its early stage have a five year survival rate between 90 and 99 per cent, whereas if it is not caught early and it spreads around the body, the five year survival rate drops to less than 50 per cent,” she said.
“This is what makes this blood test so exciting as a potential screening tool because it can pick up melanoma in its very early stages when it is still treatable.”
Currently the main way melanoma is detected is by a visual scan by a clinician with any areas of skin that are of concern excised and sent for a biopsy.
Ms Zaenker, from ECU’s Melanoma Research Group (MRG), said the new blood test could provide doctors with a powerful new tool to detect melanoma before it spreads throughout the body.
“While clinicians do a fantastic job with the tools available, relying on biopsies alone can be problematic. We know that three out of four biopsies come back negative for melanoma,” she said.
“The biopsies are quite invasive, with a minimum of 1cm by 1cm of skin excised from the patient.
“They are also costly, with previous research showing that the Australian health system spends $201 million on melanoma each year with an additional $73 million on negative biopsies.”
Antibodies provide early warning
The blood test works by detecting the autoantibodies the body produces in response to the melanoma.
“The body starts producing these antibodies as soon as melanoma first develops which is how we have been able to detect the cancer in its very early stages with this blood test. No other type of biomarker appears to be capable of detecting the cancer in blood at these early stages.” Ms Zaenker said.
“We examined a total of 1627 different types of antibodies to identify a combination of 10 antibodies that best indicated the presence of melanoma in confirmed patients relative to healthy volunteers.”
MelanomaWA Chief Executive Officer Clinton Heal knows first-hand the importance of developing new ways to detect skin cancer – he has had 34 secondary tumours removed since he was diagnosed with melanoma at the age of 22.
“At MelanomaWA we see first-hand the importance of early detection and how it’s critical to the long term survival of people diagnosed with melanoma,” he said.
“I am personally so excited to see this research transcending into clinical practice, having given of my own blood samples to the Melanoma Research Group following my diagnosis in 2005.
“My primary melanoma was not detected early, and I believe a simple blood test could have drastically improved my melanoma diagnosis and subsequent treatment since.”
MRG head Professor Mel Ziman said a follow up clinical trial to validate the findings was being organised.
“We envision this taking about three years. If this is successful we would hope to be able to have a test ready for use in pathology clinics shortly afterwards,” she said.
“The ultimate goal is for this blood test to be used to provide greater diagnostic certainty prior to biopsy and for routine screening of people who are at a higher risk of melanoma, such as those with a large number of moles or those with pale skin or a family history of the disease.”
The blood test (MelDx) has been submitted for an international patent.
Receive an email update when we add a new MELANOMA article.
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- AFL 2019: Jarryd Roughead retires, cancer, 2016 melanoma, treatmenton August 16, 2019 at 10:33 am
Retiring Hawthorn champion Jarryd Roughead has reflected on his 2016 cancer battle and how he speaks to people going through similar experiences. In May 2016, Roughead was diagnosed with a recurrence ...
- Bend is a ‘perfect storm’ for melanomaon August 16, 2019 at 12:01 am
For more details on how to check your skin or how to get involved in the War on Melanoma campaign, visit startseeingmelanoma.com Wearing sunscreen today? If the answer is no, maybe you should be.
- MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapyon August 15, 2019 at 1:38 pm
A study from Vanderbilt-Ingram Cancer Center and the Department of Veterans Affairs led by Anna Vilgelm, MD, Ph.D., and Ann Richmond, Ph.D., has identified a possible second-line treatment for ...
- A new treatment for advanced melanoma patients on Coast Liveon August 14, 2019 at 12:01 pm
HAMPTON ROADS, Va. - Melanoma is the most serious and life-threatening type of skin cancer. It is almost always treatable when caught early, but if it metastasizes, or spreads to other parts of ...
- Genetic test helped Utahns at risk for melanoma change behavior, study findson August 9, 2019 at 5:27 pm
SALT LAKE CITY — When people know they have a high genetic risk of melanoma, they are more likely to protect themselves from the sun, according to a new study. "For most genes that have been found for ...
- Combo Tx for Melanoma Ups CV Riskon August 9, 2019 at 11:11 am
Dual BRAF and MEK inhibition therapy for melanoma may carry certain cardiovascular harms, according to a meta-analysis. Across five randomized trials with a total of 2,317 patients, the addition of ...
- Melanoma Checkpoint Therapy More Potent in Combination with Nanovaccineon August 6, 2019 at 3:29 am
Dissonant signaling, which can deafen the immune system to cancer, can be replaced by something more harmonious—and therapeutic—if immunotherapies silence a note, sound another, or play an especially ...
- Scientists demonstrate a new nano-vaccine preventing the spread of melanomaon August 5, 2019 at 9:41 pm
A new nano-vaccine both slowed the progression of skin cancer in mice with a primary melanoma, and prevented its initial onset in healthy mice(Credit: vitanovski/Depositphotos) A new nano-vaccine ...
- Man bikes across America to raise awareness for melanomaon August 5, 2019 at 4:23 pm
A Waukesha County man is biking across America to raise money and awareness about melanoma. He's riding for his sister Barbie. She lost her battle with melanoma last year at the age of 58.
via Bing News